课题基金 / 基金详情

Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D

Formulation of Ambient Temperature and Humidity Stable Rabies Vaccines for Oral D
环境温度和湿度稳定的口服 D 型狂犬病疫苗的配制
批准号:
7538049
负责人:
Victor Bronshtein
金额:
$12.58万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2009-11-30
关键词:
6-PhytaseAchievementAcuteAffectAfricaAgreementAlginatesAmericasAnimalsAnthrax diseaseAsiaAttenuatedAttenuated VaccinesAvian InfluenzaBacteriaBiological AssayBiological PreservationBiteCaliberCanis familiarisCarbohydratesCenters for Disease Control and Prevention (U.S.)Central Nervous System Viral DiseasesCessation of lifeChiropteraCold ChainsConditionDNA VaccinesDataDeveloped CountriesDeveloping CountriesDevelopmentDiseaseDog BiteDomestic AnimalsDoseDropsDrug FormulationsDuodenumEatingEconomic BurdenElementsEncapsulatedEnsureEnvironmentEnzymesExposure toFatty acid glycerol estersFelis catusFerretsFoodFoxesFreeze DryingGastric JuiceGastrointestinal tract structureGelGenerationsGlassGlycoproteinsGoalsHigh temperature of physical objectHourHumanHumidityHydrogelsImmune responseImmunizationIndustryIntestinal MucosaIntestinesLeadLegal patentLifeLightLiquid substanceListeriaListeriosisLiving CostsManualsMeaslesMeasles VaccineMeasuresMeatMephitidaeMethodsMicrospheresNumbersOilsOralOral cavityPersonal SatisfactionPhasePlasticsPolymersPopulationPreventiveProbioticsProtocols documentationPublic HealthRNA VirusesRabiesRabies VaccinesRabies virusRaccoon DogsRaccoonsRangeRefrigerationReportingSalivaSalmonellaSmallpoxSolidSolutionsStomachSucroseSunlightSuspension substanceSuspensionsSystemTechnologyTemperatureTransportationTropical DiseaseTularemiaVaccinatedVaccinationVaccinesVaccinia virusVegetable OilsVegetablesViralViral VaccinesVirionVirusWeekWest Nile virusWild AnimalsYellow Fever VaccineZoonosesbasebiodefensecommercial applicationcost effectivegastrointestinal systeminnovationmeltingnovelnovel vaccinesoral vaccinepalm oilparticlepet animalpositional cloningprogramsrabies virus glycoprotein Greconstitutionsizetechnological innovationvaccine deliveryvaporization

项目摘要

项目成果

Victor Bronshtein的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):狂犬病是一种由中枢神经系统病毒感染引起的急性致命疾病,最常通过被感染(狂犬病)动物(如蝙蝠、浣熊、臭鼬、狐狸、雪貂、猫或狗)的咬伤和唾液传播。每年死于狂犬病的人数估计在4万至7万人之间。与许多人畜共患疾病一样,保护人类的唯一方法是消除动物宿主中的疾病。饲养的狗和其他宠物可以口服狂犬病疫苗,而野生动物和流浪动物则需要口服疫苗,并在食物或诱饵中注射狂犬病疫苗。目前,大约有15个州为野生动物分发食用狂犬病疫苗,试图根除这种疾病。这些疫苗的问题是它们在环境条件下不稳定,并且在动物的胃肠道系统中很容易被破坏。亟需一种新的动物口服狂犬病疫苗给药系统。疫苗必须避免阳光照射、环境温度高和湿度大。此外,必须保护它免受胃液和胆汁在十二指肠的破坏作用。该产品应在动物口中迅速溶解,而不是通过人工和/或空中投放诱饵而被破坏。我们建议将两种技术结合起来制备一种新型狂犬病疫苗,该疫苗应具有良好的产量,成本效益,在环境温度下稳定,并且更稳定地通过胃和十二指肠。蒸发保存(PBV)是由PI发明的,正在申请专利,将敏感的生物制品固定在“玻璃状态”,因此它们在环境温度下是稳定的。海藻酸盐凝胶包封已经在工业中使用了好几年,以保护疫苗免受胃肠道系统的损害。我们建议用PBV干燥海藻酸盐凝胶微球包封的狂犬病疫苗。具体目标是:1)制定使用PBV技术干燥动物狂犬病疫苗的规程。证明干燥保存的疫苗在37℃和60℃下的稳定性2。制作由病毒颗粒和保存溶液组成的海藻酸盐凝胶微球(平均直径约为100 ?),通过浸出或从颗粒中泄漏使病毒损失最小(小于10%)。3.) 制定用PBV技术干燥海藻酸盐微球包封狂犬病疫苗的方案。证明干燥保存的疫苗在37℃和60℃下的稳定性。需要在60℃下保持疫苗的短期稳定性,以便将疫苗保存在可食用的氢化油或脂肪中,以确保不受环境湿度的影响。该项目的长期目标是生产出在野外稳定的饵料,可以被野生动物食用,在胃肠道中不会被破坏,因此会在肠道中产生强烈的免疫反应。UST将与CDC和Merial公司合作,后者将提供疫苗并进行活力分析。公共卫生相关性:狂犬病每年造成的死亡人数估计在4万至7万人之间。在美国,患狂犬病的生活成本很高,而且还在不断增长,每年超过3亿美元。虽然对家养动物接种狂犬病疫苗已经有很多年了,但直到最近才开发出这种预防措施来控制野生动物的狂犬病。开发出一种将稳定的狂犬病疫苗嵌入可食用氢化油中的饵料,这样疫苗就不会受到阳光、温度、湿度和胃液等因素的影响,这样就可以给野生动物接种疫苗,使它们不会感染狂犬病,从而有助于根除这种疾病。
英文摘要
DESCRIPTION (provided by applicant): Rabies is an acute and deadly disease caused by a viral infection of the central nervous system, most often spread by a bite and saliva from an infected (rabid) animal (e.g., bats, raccoons, skunks, foxes, ferrets, cats, or dogs). The number of deaths due to rabies each year is estimated to be between 40,000-70,000. As it is for many zoonotic diseases, the only way to protect humans is to eliminate the disease in the animal reservoir. Parenteral rabies vaccination is feasible for owned dogs and other pets, whereas oral vaccination is required for wild and stray animals, with the delivery of rabies vaccine within a food or bait. Currently, about 15 states distribute edible rabies vaccines for wild animals in an attempt to eradicate the disease. The problem with these vaccines is that they are not stable in environmental conditions and are easily destroyed in the animal's gastrointestinal (GI) system. There is great need for a new oral rabies vaccine delivery system for animals. The vaccine must be protected from sunlight, high ambient temperatures and humidity. In addition, it must be protected from the damaging effect of gastric juice and bile in the duodenum. The product should readily and instantly dissolve in the animal's mouth, not be destroyed by manual and/or aerial bait distribution. We propose to combine two technologies to prepare a novel form of rabies vaccine that should have good yield, will be cost effective and should be stable at ambient temperatures and more stable traversing the stomach and duodenum. Preservation by Vaporization (PBV) was invented by the PI, has a pending patent and immobilizes sensitive biologicals in the "glass state" so they are stable at ambient temperatures. Alginate gel encapsulation has been used for several years in the industry to protect vaccines from damage in the GI system. We propose to use PBV to dry fresh rabies vaccine encapsulated in alginate gel microspheres. The specific aims are: 1.) Formulate a protocol for drying of rabies vaccines for animals using PBV technology. Demonstrate stability of the dry preserved vaccines at 37oC and 60oC 2.) Develop alginate gel micro spheres (with an average diameter of about 100 ?) comprised of the viral particles and the preservation solution with minimum (less than 10%) loss of the virus by leaching or leaking from the particles. 3.) Formulate a protocol for drying of rabies vaccines encapsulated in the alginate microspheres using PBV technology. Demonstrate stability of the dry preserved vaccines at 37oC and 60oC. The short term stability at 60oC is needed to entrap the vaccines in eatable hydrogenated oils or fats to ensure protection from ambient humidity. The long-range goal of this project is to produce bait that is stable in the wild, would be eaten by wild animals and will not be destroyed in the GI tract, so it will produce a strong immune response in the intestine. UST will partner with CDC and Merial Inc. who will provide vaccine and perform viability assays. PUBLIC HEALTH RELEVANCE: The number of deaths that rabies causes each year is estimated to be between 40,000-70,000. The cost of living with rabies in America is high and growing, exceeding $300 million per year. Although rabies vaccinations have been available for domestic animals for many years, only recently have such preventive measures been developed to control rabies in wildlife. Development of baits that would have stable rabies vaccines embedded in edible hydrogenated oils such that the vaccines are protected from the elements, including sunlight, temperature, humidity and gastric juices, could allow vaccination of wild animals so they do not get rabies, and thus could help eradicate the disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Assessment of the immunogenicity of rabies vaccine preserved by vaporization and delivered to the duodenal mucosa of gray foxes (Urocyon cinereoargenteus).
评估通过汽化保存并递送至灰狐(Urocyon cinereoargenteus)十二指肠粘膜的狂犬病疫苗的免疫原性。
DOI: 10.2460/ajvr.78.6.752
发表时间: 2017
期刊: American journal of veterinary research
影响因子: 1
作者: [Smith,ToddG, Wu,Xianfu, Ellison,JamesA, Wadhwa,Ashutosh, Franka,Richard, Langham,GregoryL, Skinner,BriannaL, Hanlon,CathleenA, Bronshtein,VictorL]
通讯作者: Bronshtein,VictorL
Thermostable Inactivated Potent Yellow Fever Vaccine
Development of a thermostable rotavirus vaccine for mucosal delivery without need for reconstitution
Development of a thermostable rotavirus vaccine for mucosal delivery withoutneed for reconstitution - Phase II
Thermostable vaginal probiotic microbicide
海外基金